Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Aim of this study is to optimize an adherence increasing intervention designed for metastatic Breast Cancer (BC) patients by applying a full factorial design in order to evaluate the optimal combination of three different intervention components.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Zdiagnozowany zaawansowany rak piersi
- •Przyjmowanie leków przeciwnowotworowych w postaci tabletek lub hormonalnych
- •Wiek powyżej 18 lat
- •Posiadanie smartfona z dostępem do internetu
- •Chęć i możliwość uczestnictwa w wizytach i procedurach badania
- •Znajomość języka włoskiego
- •Podpisana świadoma zgoda na uczestnictwo
✗ Disqualifies
- •Zaburzenia psychiczne mogące wpłynąć na zdolność wyrażenia świadomej zgody
- •Inne choroby mogące utrudnić realizację procedur badania
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- December 20, 2024
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
European Institute of Oncology
Milan, Italy
Trial contact
Gabriella Pravettoni, MD
Mara Negri
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.